Microba Life Sciences Ltd to suspend trading
Key points
- Trading suspension requested by Microba Life Sciences Ltd
- Suspension pending announcement of capital raise and break-even update
- Suspension effective until 11 June 2026
- To prevent uninformed trading and ensure orderly process
Full summary
Microba Life Sciences Ltd has requested a voluntary suspension of its securities trading effective from 5 June 2026, pending an announcement regarding a material capital raise and an update on its path to break-even. The suspension is expected to last until 11 June 2026. The company aims to finalize the capital raise and provide an update on its break-even plan by then. The suspension is intended to ensure a fair and informed market and to support the best possible outcome for shareholders.
Summary generated by a large language model. Please interpret with care.